Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients

• Main Authors: Jira Chansaenroj, Ritthideach Yorsaeng, Jiratchaya Puenpa, Nasamon Wanlapakorn, Chintana Chirathaworn, Natthinee Sudhinaraset, Manit Sripramote, Piti Chalongviriyalert, Supunee Jirajariyavej, Phatharaporn Kiatpanabhikul, Jatuporn Saiyarin, Chulikorn Soudon, Orawan Thienfaidee, Thitisan Palakawong Na Ayuthaya, Chantapat Brukesawan, Duangnapa Intharasongkroh, Dootchai Chaiwanichsiri, Mila Issarasongkhram, Rungrueng Kitphati, Anek Mungaomklang, Arunee Thitithanyanont, Pijaya Nagavajara, Yong Poovorawan
• Other Authors: Bangkok Metropolitan Administration General Hospital
• Format: Article
• Published: 2022
• Subjects: Multidisciplinary
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/75463

Understanding antibody responses after natural severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can guide the coronavirus disease 2019 (COVID-19) vaccine schedule, especially in resource-limited settings. This study aimed to assess the dynamics of SARS-CoV-2 antibodies, includi...